Saratoga Research & Investment Management Eli Lilly & CO Transaction History
Saratoga Research & Investment Management
- $1.98 Billion
- Q4 2024
A detailed history of Saratoga Research & Investment Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Saratoga Research & Investment Management holds 31,307 shares of LLY stock, worth $27.3 Million. This represents 1.22% of its overall portfolio holdings.
Number of Shares
31,307Holding current value
$27.3 Million% of portfolio
1.22%Shares
2 transactions
Others Institutions Holding LLY
# of Institutions
4,183Shares Held
752MCall Options Held
8.6MPut Options Held
9.97M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$84.5 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA74.2MShares$64.7 Billion1.03% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$57.4 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$44.7 Billion26.72% of portfolio
-
State Street Corp Boston, MA34.3MShares$29.9 Billion1.07% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $828B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...